Durlobactam

度洛巴坦

Report date: 2024/01/18 15:10:46
NME

Base Information

Drug NameDurlobactam
Drug Alias NameETX-2514ETX-2514-sodium
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial beta-lactamase TEM inhibitors
TargetsBacterial beta-lactamase TEM
Therapy Area/IndicationsAcinetobacter Baumannii Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEntasis TherapeuticsEntasis Therapeutics Holdings Inc
Active IndicationsN/A
Inactive IndicationsAcinetobacter Baumannii Infections

Other Information

ATC CodeN/A
Related LinksDrugBank